Pharmaceutical Services Federal Committee of Inquiry

Health and Aged Care
Provisions for the Pharmaceutical Services Committee of Inquiry are under the National Health Act 1953. The Act allows a Committee to be established at either a state or federal level. The current Federal level committee was most recently established in 2015 to investigate matters of suspected non-compliance with a pharmacist's approval to supply Pharmaceutical Benefits Scheme (PBS) medicines, including the conditions of approval. In particular, where PBS medicines are being supplied at premises for which the pharmacist is not approved. The Act specifies the membership of the Committee consists of four pharmacists appointed by the Minister for Health and Aged Care as well as the Secretary of the Department of Health and Aged Care (or their delegate who must be a Departmental officer who is a medical practitioner or pharmacist).

Further information

  • Type of Body

    E. Statutory office holder, offices and committees

  • Established By / Under

    Act / Regulation

  • Established By/Under More info

    National Health Act 1953

  • Paid Members?


  • Max No. of Board/Committee Members


  • Annual Report Prepared and tabled?


  • Classification

    B. Secondary statutory structure

  • Function Categorization

    Regulatory / Review / Inquiry / Commission

  • Creation Date

Current board appointments

Position Appointee Start Date End Date
Chair Ms. Renae Beardmore 20 April 2021 20 April 2099
Member Dr. Helen Benson 22 April 2024 22 April 2099
Member Dr. Nick Simpson 22 November 2018 1 January 2099
Member Ms Ms. Juliana Sestan 20 April 2021 Determined by the appointer
Member Ms. Helen Dowling 20 April 2021 Determined by the appointer
Last updated: